Focus Partners Wealth

Position in NBIX — Neurocrine Biosciences Inc

CIK 1542153 ST LOUIS, MO

Position in NBIX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$13,145,108

+$2,561,776 QoQ

Shares Held

77,994

-2.9% QoQ

Ownership

0.077%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#139

of 772 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 66% Shared 0% None 34%

Healthcare · as of Jun 30, 2026

Focus Partners Wealth holds $57,760,663 across 23 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (22.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc This page	77,994	$13,145,108
2	ZTS	Zoetis Inc.	180,366	$12,961,100
3	TAK	Takeda Pharmaceutical Co Ltd	679,950	$10,899,598
4	LNTH	Lantheus Holdings, Inc.	67,843	$7,526,502
5	UTHR	UNITED THERAPEUTICS Corp	6,078	$3,293,242
6	ALKS	Alkermes plc.	41,596	$2,179,630
7	HLN	Haleon plc	221,287	$2,064,607
8	TEVA	Teva Pharmaceutical Industries Ltd	35,560	$1,204,772

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,145,108	77,994	-2.9%	Shares	Sole	2026-08-12
2026-03-31	$10,583,332	80,335	+14.9%	Shares	Sole	2026-05-15
2025-12-31	$9,918,739	69,934	+6.2%	Shares	Sole	2026-02-13
2025-09-30	$9,240,092	65,822	+15.1%	Shares	Sole	2025-11-14
2025-06-30	$7,186,577	57,177	+13.5%	Shares	Sole	2025-08-14
2025-03-31	$5,573,244	50,391	-1.3%	Shares	Sole	2025-05-20
2024-12-31	$6,972,147	51,078	+9.5%	Shares	Sole	2025-05-20
2024-09-30	$5,375,934	46,658	+1.7%	Shares	Sole	2024-11-14
2024-06-30	$6,315,748	45,876	+0.9%	Shares	Sole	2024-08-15
2024-03-31	$6,272,463	45,479	+12.5%	Shares	Sole	2024-05-16
2023-12-31	$5,325,870	40,421	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.